The effectiveness and cost-effectiveness of temozolomide for the treatment of recurrent malignant glioma: a rapid and systematic review

• 1 January 2001
• journal article
• review article
• Published by National Institute for Health and Care Research in Health Technology Assessment
• Vol. 5  (13) , 1-73
• https://doi.org/10.3310/hta5130

Abstract

Keywords

• TREATMENT
• COST EFFECTIVENESS
• RECURRENT MALIGNANT
• ASSESSMENT VOLUME
• SYSTEMATIC REVIEW
• HEALTH TECHNOLOGY
• MALIGNANT GLIOMA
• REVIEW HEALTH
• TECHNOLOGY ASSESSMENT

Funding Information

• Health Technology Assessment Programme (00/11/01)